Doxorubicin treatment modulates chemoresistance and affects the cell cycle in two canine mammary tumour cell lines
Abstract Background Doxorubicin (DOX) is widely used in both human and veterinary oncology although the onset of multidrug resistance (MDR) in neoplastic cells often leads to chemotherapy failure. Better understanding of the cellular mechanisms that circumvent chemotherapy efficacy is paramount. The...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | BMC Veterinary Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12917-020-02709-5 |